|
1
|
Jonasch E, Gao J and Rathmell WK: Renal
cell carcinoma. BMJ. 349:g47972014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ljungberg B, Campbell SC, Choi HY, Jacqmin
D, Lee JE, Weikert S and Kiemeney LA: The epidemiology of renal
cell carcinoma. Eur Urol. 60:615–621. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gupta S, Kang HC, Ganeshan DM, Bathala TK
and Kundra V: Diagnostic approach to hereditary renal cell
carcinoma. AJR Am J Roentgenol. 204:1031–1041. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bex A, Jonasch E, Kirkali Z, Mejean A,
Mulders P, Oudard S, Patard JJ, Powles T, van Poppel H and Wood CG:
Integrating surgery with targeted therapies for renal cell
carcinoma: Current evidence and ongoing trials. Eur Urol.
58:819–828. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wyczólkowski M, Klima W, Bieda W and Walas
K: Spontaneous regression of hepatic metastases after nephrectomy
and metastasectomy of renal cell carcinoma. Urol Int. 66:119–120.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
International Human Genome Sequencing
Consortium: Finishing the euchromatic sequence of the human genome.
Nature. 431:931–945. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bergmann JH and Spector DL: Long
non-coding RNAs: Modulators of nuclear structure and function. Curr
Opin Cell Biol. 26:10–18. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guttman M, Garber M, Levin JZ, Donaghey J,
Robinson J, Adiconis X, Fan L, Koziol MJ, Gnirke A, Nusbaum C, et
al: Ab initio reconstruction of cell type-specific transcriptomes
in mouse reveals the conserved multi-exonic structure of lincRNAs.
Nat Biotechnol. 28:503–510. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cabili MN, Trapnell C, Goff L, Koziol M,
Tazon-Vega B, Regev A and Rinn JL: Integrative annotation of human
large intergenic noncoding RNAs reveals global properties and
specific subclasses. Genes Dev. 25:1915–1927. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guttman M, Amit I, Garber M, French C, Lin
MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al:
Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs in mammals. Nature. 458:223–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Geisler S and Coller J: RNA in unexpected
places: Long non-coding RNA functions in diverse cellular contexts.
Nat Rev Mol Cell Biol. 14:699–712. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tripathi V, Shen Z, Chakraborty A, Giri S,
Freier SM, Wu X, Zhang Y, Gorospe M, Prasanth SG, Lal A and
Prasanth KV: Long noncoding RNA MALAT1 controls cell cycle
progression by regulating the expression of oncogenic transcription
factor B-MYB. PLoS Genet. 9:e10033682013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hammond SM: An overview of microRNAs. Adv
Drug Deliv Rev. 87:3–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ye W, Lv Q, Wong CK, Hu S, Fu C, Hua Z,
Cai G, Li G, Yang BB and Zhang Y: The effect of central loops in
miRNA: MRE duplexes on the efficiency of miRNA-mediated gene
regulation. PLoS One. 3:e17192008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Amirkhah R, Schmitz U, Linnebacher M,
Wolkenhauer O and Farazmand A: MicroRNA-mRNA interactions in
colorectal cancer and their role in tumor progression. Genes
Chromosomes Cancer. 54:129–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang C, Hu DZ and Liu JZ: Identification
of critical TF-miRNA-mRNA regulation loops for colorectal cancer
metastasis. Genet Mol Res. 14:5485–5495. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and
Ma W: ceRNA in cancer: Possible functions and clinical
implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Militello G, Weirick T, John D, Döring C,
Dimmeler S and Uchida S: Screening and validation of lncRNAs and
circRNAs as miRNA sponges. Brief Bioinform. 18:780–788.
2017.PubMed/NCBI
|
|
23
|
Kallen AN, Zhou XB, Xu J, Qiao C, Ma J,
Yan L, Lu L, Liu C, Yi JS, Zhang H, et al: The imprinted H19 lncRNA
antagonizes let-7 microRNAs. Mol Cell. 52:101–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Imig J, Brunschweiger A, Brümmer A,
Guennewig B, Mittal N, Kishore S, Tsikrika P, Gerber AP, Zavolan M
and Hall J: miR-CLIP capture of a miRNA targetome uncovers a
lincRNA H19-miR-106a interaction. Nat Chem Biol. 11:107–114. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cesana M, Cacchiarelli D, Legnini I,
Santini T, Sthandier O, Chinappi M, Tramontano A and Bozzoni I: A
long noncoding RNA controls muscle differentiation by functioning
as a competing endogenous RNA. Cell. 147:358–369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xia T, Liao Q, Jiang X, Shao Y, Xiao B, Xi
Y and Guo J: Long noncoding RNA associated-competing endogenous
RNAs in gastric cancer. Sci Rep. 4:60882014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang J, Fan D, Jian Z, Chen GG and Lai
PB: Cancer specific long noncoding RNAs show differential
expression patterns and competing endogenous RNA potential in
hepatocellular carcinoma. PLoS One. 10:e01410422015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou X, Liu J and Wang W: Construction and
investigation of breast-cancer-specific ceRNA network based on the
mRNA and miRNA expression data. IET Syst Biol. 8:96–103. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou M, Diao Z, Yue X, Chen Y, Zhao H,
Cheng L and Sun J: Construction and analysis of dysregulated
lncRNA-associated ceRNA network identified novel lncRNA biomarkers
for early diagnosis of human pancreatic cancer. Oncotarget.
7:56383–56394. 2016.PubMed/NCBI
|
|
30
|
Wotschofsky Z, Gummlich L, Liep J, Stephan
C, Kilic E, Jung K, Billaud JN and Meyer HA: Integrated microRNA
and mRNA signature associated with the transition from the locally
confined to the metastasized clear cell renal cell carcinoma
exemplified by miR-146-5p. PLoS One. 11:e01487462016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fachel AA, Tahira AC, Vilella-Arias SA,
Maracaja-Coutinho V, Gimba ER, Vignal GM, Campos FS, Reis EM and
Verjovski-Almeida S: Expression analysis and in silico
characterization of intronic long noncoding RNAs in renal cell
carcinoma: Emerging functional associations. Mol Cancer.
12:1402013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang X, Chen X, Han W, Ruan A, Chen L,
Wang R, Xu Z, Xiao P, Lu X, Zhao Y, et al: miR-200c targets CDK2
and suppresses tumorigenesis in renal cell carcinoma. Mol Cancer
Res. 13:1567–1577. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jeggari A, Marks DS and Larsson E:
miRcode: A map of putative microRNA target sites in the long
non-coding transcriptome. Bioinformatics. 28:2062–2063. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hsu SD, Tseng YT, Shrestha S, Lin YL,
Khaleel A, Chou CH, Chu CF, Huang HY, Lin CM, Ho SY, et al:
miRTarBase update 2014: An information resource for experimentally
validated miRNA-target interactions. Nucleic Acids Res. 42:D78–D85.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Walsh AL, Tuzova AV, Bolton EM, Lynch TH
and Perry AS: Long noncoding RNAs and prostate carcinogenesis: The
missing ‘linc’? Trends Mol Med. 20:428–436. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang F, Zhang L and Zhang C: Long
noncoding RNAs and tumorigenesis: Genetic associations, molecular
mechanisms, and therapeutic strategies. Tumour Biol. 37:163–175.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang H, Niu L, Jiang S, Zhai J, Wang P,
Kong F and Jin X: Comprehensive analysis of aberrantly expressed
profiles of lncRNAs and miRNAs with associated ceRNA network in
muscle-invasive bladder cancer. Oncotarget. 7:86174–86185. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hauptman N and Glavač D: Long non-coding
RNA in cancer. Int J Mol Sci. 14:4655–4669. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Han D, Gao X, Wang M, Qiao Y, Xu Y, Yang
J, Dong N, He J, Sun Q, Lv G, et al: Long noncoding RNA H19
indicates a poor prognosis of colorectal cancer and promotes tumor
growth by recruiting and binding to eIF4A3. Oncotarget.
7:22159–22173. 2016.PubMed/NCBI
|
|
41
|
Honda K: The biological role of actinin-4
(ACTN4) in malignant phenotypes of cancer. Cell Biosci. 5:412015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Honda K, Yamada T, Endo R, Ino Y, Gotoh M,
Tsuda H, Yamada Y, Chiba H and Hirohashi S: Actinin-4, a novel
actin-bundling protein associated with cell motility and cancer
invasion. J Cell Biol. 140:1383–1393. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yamamoto S, Tsuda H, Honda K, Onozato K,
Takano M, Tamai S, Imoto I, Inazawa J, Yamada T and Matsubara O:
Actinin-4 gene amplification in ovarian cancer: A candidate
oncogene associated with poor patient prognosis and tumor
chemoresistance. Mod Pathol. 22:499–507. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kikuchi S, Honda K, Tsuda H, Hiraoka N,
Imoto I, Kosuge T, Umaki T, Onozato K, Shitashige M, Yamaguchi U,
et al: Expression and gene amplification of actinin-4 in invasive
ductal carcinoma of the pancreas. Clin Cancer Res. 14:5348–5356.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Rojas AM, Fuentes G, Rausell A and
Valencia A: The Ras protein superfamily: Evolutionary tree and role
of conserved amino acids. J Cell Biol. 196:189–201. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen D, Guo J, Miki T, Tachibana M and
Gahl WA: Molecular cloning of two novel rab genes from human
melanocytes. Gene. 174:129–134. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Abba MC, Hu Y, Sun H, Drake JA, Gaddis S,
Baggerly K, Sahin A and Aldaz CM: Gene expression signature of
estrogen receptor alpha status in breast cancer. BMC Genomics.
6:372005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Luther T, Kotzsch M, Meye A, Langerholc T,
Füssel S, Olbricht N, Albrecht S, Ockert D, Muehlenweg B, Friedrich
K, et al: Identification of a novel urokinase receptor splice
variant and its prognostic relevance in breast cancer. Thromb
Haemost. 89:705–717. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kotzsch M, Farthmann J, Meye A, Fuessel S,
Baretton G, Tjan-Heijnen VC, Schmitt M, Luther T, Sweep FC,
Magdolen V and Span PN: Prognostic relevance of uPAR-del4/5 and
TIMP-3 mRNA expression levels in breast cancer. Eur J Cancer.
41:2760–2768. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sato S, Kopitz C, Grismayer B, Beaufort N,
Reuning U, Schmitt M, Luther T, Kotzsch M, Krüger A and Magdolen V:
Overexpression of the urokinase receptor mRNA splice variant
uPAR-del4/5 affects tumor-associated processes of breast cancer
cells in vitro and in vivo. Breast Cancer Res Treat. 127:649–657.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kunkle BW, Yoo C and Roy D: Reverse
engineering of modified genes by Bayesian network analysis defines
molecular determinants critical to the development of glioblastoma.
PLoS One. 8:e641402013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Usó M, Jantus-Lewintre E, Sirera R,
Bremnes RM and Camps C: miRNA detection methods and clinical
implications in lung cancer. Future Oncol. 10:2279–2292. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yoshino H, Seki N, Itesako T, Chiyomaru T,
Nakagawa M and Enokida H: Aberrant expression of microRNAs in
bladder cancer. Nat Rev Urol. 10:396–404. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kumra H and Reinhardt DP:
Fibronectin-targeted drug delivery in cancer. Adv Drug Deliv Rev.
97:101–110. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Muller PA and Vousden KH: Mutant p53 in
cancer: New functions and therapeutic opportunities. Cancer Cell.
25:304–317. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Huang H, Weng H, Zhou H and Qu L:
Attacking c-Myc: Targeted and combined therapies for cancer. Curr
Pharm Des. 20:6543–6554. 2014. View Article : Google Scholar : PubMed/NCBI
|
